Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hyper-elevated prostate-specific antigen levels are not always carcinoma

Nathan Lawrentschuk¹, Adee-Jonathan Davidson, Michael R Hurley

¹University of Melbourne, Department of Surgery, Austin Hospital, Heidelberg, Victoria, 3084, Australia.

British Journal of Hospital Medicine (London, England : 2005)

|March 28, 2006

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tumour-based epigenetic signatures as markers of prostate cancer aggressiveness after radical prostatectomy.

British journal of cancer·2025

Same author

The Blind Spot of Prostate-Specific Membrane Antigen Positron Emission Tomography Staging? Intraductal Carcinoma of the Prostate Is Overrepresented in Patients With No Uptake Pattern on Prostate-Specific Membrane Antigen Positron Emission Tomography and High-Grade Prostate Cancer.

The Journal of urology·2025

Same author

Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta-analysis.

BJU international·2025

Same author

Urogeriatrics: a critical perspective for future urologists.

BJU international·2024

Same author

Lessons from a population-based bladder cancer registry: exploring why survival is not improving.

BJU international·2024

Same author

Cost Effectiveness of Systemic Treatment Intensification for Metastatic Hormone-sensitive Prostate Cancer: Is Triplet Therapy Cost Effective?

European urology oncology·2023